Ryanair

02/12/20 -"Seeing the encouraging progress in vaccine developments and the hopeful putting-into-service of the efficient 737MAX aircraft by next summer, we are now more optimistic for Ryanair’s longer-term ..."

PDF page sample
Pages
68
Language
English
Published on
02/12/20
Download
You may also be interested by these reports :
07/11/25
Today’s negative market reaction is primarily due to the Q3 glitch and a less optimistic market sentiment regarding extended yield and load factor ...
06/11/25
DHL’s Q3 results surpassed the company-compiled consensus on EBIT, supported by better-than-expected profitability in P&P and eCommerce, and ...
06/11/25
Air France-KLM’s Q3 results fell slightly below consensus expectations. Despite reaffirming FY objectives and management’s optimism about unit cost ...
03/11/25
Ryanair’s H1 results aligned with consensus expectations. The interim dividend was below our forecast, but we anticipate a recovery at year-end. FY ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO